Differential effects of IL-10 on prostaglandin H synthase-2 expression and prostaglandin E2 biosynthesis between spleen and bone marrow macrophages
Authors:
- 18 January 2005
- journal article
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 77 (4) , 544-551
Abstract
Different populations of mononuclear phagocytes (MØ) show considerable diversity of cellular function including prostaglandin E2 (PGE2) biosynthesis. Certain bacterial components enhance PGE2 biosynthesis differentially in selected populations of MØ. Interleukin (IL)-10 is proposed to inhibit modulation of PGE2 biosynthesis by down-regulating prostaglandin G/H synthase-2 (PGHS-2) expression. To assess whether IL-10 regulates PGE2 biosynthesis and PGHS-2 expression, splenic and bone marrow MØ were isolated from IL-10-deficient (IL-10−/−), C57Bl/6 [wild-type (WT) control], and Balb/c (comparison control) mice and were treated with lipopolysaccharide (LPS) and/or interferon-γ (IFN-γ) as a model of bacterial inflammation. LPS-induced PGHS-2 expression was similar for splenic MØ isolated from the three strains of mice. However, PGE2 released by LPS-treated splenic MØ was significantly higher in IL-10−/− and Balb/c than in WT cells. In the presence of LPS and IFN-γ, PGHS-2 expression and PGE2 release by IL-10−/− and Balb/c splenic MØ were enhanced compared with stimulation with LPS alone or IFN-γ alone. However, there was no significant increase in PGE2 release from WT splenic MØ treated with LPS plus IFN-γ despite increased PGHS-2 expression. In sharp contrast, PGHS-2 expression and PGE2 release by bone marrow MØ were greatly enhanced in IL-10−/− cells compared with control cells. Our results indicate that IL-10 regulation of MØ PGE2 biosynthesis and PGHS-2 expression is compartment-dependent and that PGE2 production is not linked directly to PGHS-2 levels. Furthermore, our findings emphasize strain-specific differences between C57Bl/6 and Balb/c mice, and Balb/c appears more similar to the IL-10−/− than to the C57Bl/6 with respect to prostanoid production.Keywords
Funding Information
- National Institutes of Health (HL71711)
- Department of Defense (DAMD17-03-1-0004)
This publication has 46 references indexed in Scilit:
- Th1 AdjuvantN-Acetyl-d-Glucosamine Polymer Up-Regulates Th1 Immunity but Down-Regulates Th2 Immunity against a Mycobacterial Protein (MPB-59) in Interleukin-10-Knockout and Wild-Type MiceInfection and Immunity, 2001
- Interferon Regulatory Factor (Irf)-1 and Irf-2 Regulate Interferon γ–Dependent Cyclooxygenase 2 ExpressionJournal of Experimental Medicine, 2000
- Regulation of Cyclooxygenase-2 by Interferon γ and Transforming Growth Factor α in Normal Human Epidermal Keratinocytes and Squamous Carcinoma CellsJournal of Biological Chemistry, 1999
- Interleukin‐1α and tumour necrosis factor‐α modulate airway smooth muscle DNA synthesis by induction of cyclo‐oxygenase‐2: inhibition by dexamethasone and fluticasone propionateBritish Journal of Pharmacology, 1999
- MAP Kinase Pathways as a Route for Regulatory Mechanisms of IL-10 and IL-4 Which Inhibit COX-2 Expression in Human MonocytesBiochemical and Biophysical Research Communications, 1998
- Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production.Journal of Experimental Medicine, 1995
- Lipopolysaccharide induces prostaglandin H synthase-2 in alveolar macrophagesBiochemical and Biophysical Research Communications, 1992
- Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.Journal of Experimental Medicine, 1991
- BCG-Induced Macrophages as Suppressor CellsCancer Investigation, 1983
- Macrophages synthesise and release prostaglandins in response to inflammatory stimuliNature, 1977